Cargando…
Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia
AIM: Validating the vulnerabilities and pathologies underlying treatment‐resistant schizophrenia (TRS) is an important challenge in optimizing treatment. Gyrification and surface area (SA), reflecting neurodevelopmental features, have been linked to genetic vulnerability to schizophrenia. The aim of...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092309/ https://www.ncbi.nlm.nih.gov/pubmed/36165228 http://dx.doi.org/10.1111/pcn.13482 |
_version_ | 1785023315090341888 |
---|---|
author | Kitajima, Kazutoshi Tamura, Shunsuke Sasabayashi, Daiki Nakajima, Shinichiro Iwata, Yusuke Ueno, Fumihiko Takai, Yoshifumi Takahashi, Junichi Caravaggio, Fernando Mar, Wanna Torres‐Carmona, Edgardo Noda, Yoshihiro Gerretsen, Philip de Luca, Vincenzo Mimura, Masaru Hirano, Shogo Nakao, Tomohiro Onitsuka, Toshiaki Remington, Gary Graff‐Guerrero, Ariel Hirano, Yoji |
author_facet | Kitajima, Kazutoshi Tamura, Shunsuke Sasabayashi, Daiki Nakajima, Shinichiro Iwata, Yusuke Ueno, Fumihiko Takai, Yoshifumi Takahashi, Junichi Caravaggio, Fernando Mar, Wanna Torres‐Carmona, Edgardo Noda, Yoshihiro Gerretsen, Philip de Luca, Vincenzo Mimura, Masaru Hirano, Shogo Nakao, Tomohiro Onitsuka, Toshiaki Remington, Gary Graff‐Guerrero, Ariel Hirano, Yoji |
author_sort | Kitajima, Kazutoshi |
collection | PubMed |
description | AIM: Validating the vulnerabilities and pathologies underlying treatment‐resistant schizophrenia (TRS) is an important challenge in optimizing treatment. Gyrification and surface area (SA), reflecting neurodevelopmental features, have been linked to genetic vulnerability to schizophrenia. The aim of this study was to identify gyrification and SA abnormalities specific to TRS. METHODS: We analyzed 3T magnetic resonance imaging findings of 24 healthy controls (HCs), 20 responders to first‐line antipsychotics (FL‐Resp), and 41 patients with TRS, including 19 clozapine responders (CLZ‐Resp) and 22 FL‐ and clozapine‐resistant patients (patients with ultratreatment‐resistant schizophrenia [URS]). The local gyrification index (LGI) and associated SA were analyzed across groups. Diagnostic accuracy was verified by receiver operating characteristic curve analysis. RESULTS: Both CLZ‐Resp and URS had lower LGI values than HCs (P = 0.041, Hedges g [g (H)] = 0.75; P = 0.013, g (H) = 0.96) and FL‐Resp (P = 0.007, g (H) = 1.00; P = 0.002, g (H) = 1.31) in the left medial parietal cortex (Lt‐MPC). In addition, both CLZ‐Resp and URS had lower SA in the Lt‐MPC than FL‐Resp (P < 0.001, g (H) = 1.22; P < 0.001, g (H) = 1.75). LGI and SA were positively correlated in non‐TRS (FL‐Resp) (ρ = 0.64, P = 0.008) and TRS (CLZ‐Resp + URS) (ρ = 0.60, P < 0.001). The areas under the receiver operating characteristic curve for non‐TRS versus TRS with LGI and SA in the Lt‐MPC were 0.79 and 0.85, respectively. SA in the Lt‐MPC was inversely correlated with negative symptoms (ρ = −0.40, P = 0.018) and clozapine plasma levels (ρ = −0.35, P = 0.042) in TRS. CONCLUSION: LGI and SA in the Lt‐MPC, a functional hub in the default‐mode network, were abnormally reduced in TRS compared with non‐TRS. Thus, altered LGI and SA in the Lt‐MPC might be structural features associated with genetic vulnerability to TRS. |
format | Online Article Text |
id | pubmed-10092309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons Australia, Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-100923092023-04-13 Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia Kitajima, Kazutoshi Tamura, Shunsuke Sasabayashi, Daiki Nakajima, Shinichiro Iwata, Yusuke Ueno, Fumihiko Takai, Yoshifumi Takahashi, Junichi Caravaggio, Fernando Mar, Wanna Torres‐Carmona, Edgardo Noda, Yoshihiro Gerretsen, Philip de Luca, Vincenzo Mimura, Masaru Hirano, Shogo Nakao, Tomohiro Onitsuka, Toshiaki Remington, Gary Graff‐Guerrero, Ariel Hirano, Yoji Psychiatry Clin Neurosci Regular Articles AIM: Validating the vulnerabilities and pathologies underlying treatment‐resistant schizophrenia (TRS) is an important challenge in optimizing treatment. Gyrification and surface area (SA), reflecting neurodevelopmental features, have been linked to genetic vulnerability to schizophrenia. The aim of this study was to identify gyrification and SA abnormalities specific to TRS. METHODS: We analyzed 3T magnetic resonance imaging findings of 24 healthy controls (HCs), 20 responders to first‐line antipsychotics (FL‐Resp), and 41 patients with TRS, including 19 clozapine responders (CLZ‐Resp) and 22 FL‐ and clozapine‐resistant patients (patients with ultratreatment‐resistant schizophrenia [URS]). The local gyrification index (LGI) and associated SA were analyzed across groups. Diagnostic accuracy was verified by receiver operating characteristic curve analysis. RESULTS: Both CLZ‐Resp and URS had lower LGI values than HCs (P = 0.041, Hedges g [g (H)] = 0.75; P = 0.013, g (H) = 0.96) and FL‐Resp (P = 0.007, g (H) = 1.00; P = 0.002, g (H) = 1.31) in the left medial parietal cortex (Lt‐MPC). In addition, both CLZ‐Resp and URS had lower SA in the Lt‐MPC than FL‐Resp (P < 0.001, g (H) = 1.22; P < 0.001, g (H) = 1.75). LGI and SA were positively correlated in non‐TRS (FL‐Resp) (ρ = 0.64, P = 0.008) and TRS (CLZ‐Resp + URS) (ρ = 0.60, P < 0.001). The areas under the receiver operating characteristic curve for non‐TRS versus TRS with LGI and SA in the Lt‐MPC were 0.79 and 0.85, respectively. SA in the Lt‐MPC was inversely correlated with negative symptoms (ρ = −0.40, P = 0.018) and clozapine plasma levels (ρ = −0.35, P = 0.042) in TRS. CONCLUSION: LGI and SA in the Lt‐MPC, a functional hub in the default‐mode network, were abnormally reduced in TRS compared with non‐TRS. Thus, altered LGI and SA in the Lt‐MPC might be structural features associated with genetic vulnerability to TRS. John Wiley & Sons Australia, Ltd 2022-10-27 2023-01 /pmc/articles/PMC10092309/ /pubmed/36165228 http://dx.doi.org/10.1111/pcn.13482 Text en © 2022 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Regular Articles Kitajima, Kazutoshi Tamura, Shunsuke Sasabayashi, Daiki Nakajima, Shinichiro Iwata, Yusuke Ueno, Fumihiko Takai, Yoshifumi Takahashi, Junichi Caravaggio, Fernando Mar, Wanna Torres‐Carmona, Edgardo Noda, Yoshihiro Gerretsen, Philip de Luca, Vincenzo Mimura, Masaru Hirano, Shogo Nakao, Tomohiro Onitsuka, Toshiaki Remington, Gary Graff‐Guerrero, Ariel Hirano, Yoji Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia |
title | Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia |
title_full | Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia |
title_fullStr | Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia |
title_full_unstemmed | Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia |
title_short | Decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia |
title_sort | decreased cortical gyrification and surface area in the left medial parietal cortex in patients with treatment‐resistant and ultratreatment‐resistant schizophrenia |
topic | Regular Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092309/ https://www.ncbi.nlm.nih.gov/pubmed/36165228 http://dx.doi.org/10.1111/pcn.13482 |
work_keys_str_mv | AT kitajimakazutoshi decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT tamurashunsuke decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT sasabayashidaiki decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT nakajimashinichiro decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT iwatayusuke decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT uenofumihiko decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT takaiyoshifumi decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT takahashijunichi decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT caravaggiofernando decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT marwanna decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT torrescarmonaedgardo decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT nodayoshihiro decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT gerretsenphilip decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT delucavincenzo decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT mimuramasaru decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT hiranoshogo decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT nakaotomohiro decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT onitsukatoshiaki decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT remingtongary decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT graffguerreroariel decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia AT hiranoyoji decreasedcorticalgyrificationandsurfaceareaintheleftmedialparietalcortexinpatientswithtreatmentresistantandultratreatmentresistantschizophrenia |